StonvexLoading…
StonvexCore line items from XOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-11 | Q1 2024 2024-03-31 | Q1 2023 2023-03-31 | Q3 2021 2021-09-30 | Q3 2020 2020-09-30 |
|---|---|---|---|---|---|
Revenue | $14.44M | $12.63M | $4.43M | $1.75M | $1.70M |
Operating Income | Not available | $-10.24M | $-20.03M | $-27.70M | $-6.86M |
Net Income | Not available | $-11.00M | $-24.33M | $11.96M | $-9.04M |
EPS (Diluted) | $-0.59 | $-1.80 | $-4.32 | $0.14 | $-0.13 |
Total Assets | Not available | $134.98M | $162.22M | $251.78M | $523.54K |
Total Liabilities | Not available | $67.17M | $72.46M | $89.84M | Not available |
Cash & Equivalents | Not available | $46.17M | $36.49M | $207.39M | $154.43K |
Free Cash Flow OCF − CapEx | Not available | $-14.62M | $-15.58M | $-56.48M | $-10.28M |
Shares Outstanding | Not available | 7.75M | 169.83M | 162.91M | 72.14M |